Micro Emerging Active

ImmunityBio Surat Peringatan FDA

Skor
0,4
Kecepatan
▲ 0,0
Artikel
4
Sumber
1

Ringkasan

Sebuah artikel termasuk dalam narasi ini jika artikel tersebut membahas surat peringatan FDA yang diterima oleh ImmunityBio.

Artikel Terkait

ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC

Yahoo Finance · Mar 25, 2026
Mixed

Why ImmunityBio Stock Is Down More Than 20% Today

Yahoo Finance · Mar 24, 2026
Bearish

Sumber

Jim Cramer on ImmunityBio: “I Would Encourage You to Own … Yahoo Finance
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy … Yahoo Finance
ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include … Yahoo Finance
Why ImmunityBio Stock Is Down More Than 20% Today Yahoo Finance

Lini Waktu

Terakhir Diperbarui Mar 24, 2026